Skip to content

Vericel VCEL Total Equity

Total Equity at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$12.67B+2.2%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$406.62M+17.0%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
$278.7M+118%
Globus Medical logo
Globus MedicalGMED
$4.73B+15.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's total equity?
Vericel (VCEL) reported total equity of $356.23M in Q1 2026.
How has Vericel's total equity changed year-over-year?
Vericel's total equity increased by 20.6% year-over-year, from $295.49M to $356.23M.
What is the long-term trend for Vericel's total equity?
Over 5 years (2020 to 2025), Vericel's total equity has grown at a 21.4% compound annual growth rate (CAGR), from $134.26M to $354.64M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.